|
Jia Bei Wang, Researcher, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Pathogenesis | Metabolism | Immune Microenvironment | Targeted Therapy | Drug Resistance | Hepatobiliary Tumors | Cancer Research | Clinical Diagnosis | Basic Research | Oncology |
|
Feng Shao, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Non-Coding Rna | Chemotherapy Resistance | Pancreatic Cancer | Stellate Cells | Cancer Progression | Exosomes | Diagnosis | Targeted Therapy | Mechanism | Oncology |
|
Wei-Fu Lv, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Drug-Loaded Microspheres | Transcatheter Arterial Chemoembolization | Malignant Tumors | Mechanism | Liver Cancer | Gut Microbiota | Disease Progression | Tace | Targeted Therapy | Immunotherapy |
|
Qiang Xuan, Chief Physician, Director of Urolithiasis Subspecialty
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Non-Coding Rna | Prostate Tumors | Mechanism | Pathogenesis | Prostate Cancer | Urinary Tract | Stones | Research | Oncology | Urology |
|
Bairong Xia, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Gynecological Oncology | Molecular Mechanisms | Targeted Therapy | Tumor Microenvironment | Treatment Resistance | Comprehensive Therapy | Immunotherapy | Cancer Research | Oncology | Clinical Studies |
|
Zhu Chen, Chief Physician, Director of Rheumatology and Immunology Department
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Rheumatoid Arthritis | Targeted Therapy | Osteoimmunology | Systemic Lupus Erythematosus | Pathogenesis | Autoimmune Diseases | Immunology | Th2 Immune Response | Molecular Mechanisms | Clinical Research |
|
Qingshan Ji, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Non-Coding Rna | Diabetic Retinopathy | Gene Polymorphism | Cataracts | Gene Mutation | Congenital Cataracts | Functional Mechanism | Pathogenesis | Ophthalmology | Research |
|
Xingbing Wang, Chief Physician, Deputy Director of Hematology
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Immunotherapy | Hematological Tumors | Clinical Research | Translational Research | Chemotherapy | Molecular Therapy | Targeted Therapy | Cell Therapy | Oncology | Hematology |
|
Nan Nan Lu, Chief Physician, Director of Breast Tumor Internal Medicine Subspecialty
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Nano-Drug Delivery | Tumor Microenvironment | Anti-Tumor Mechanism | Breast Tumors | Clinical Research | Vaccine Therapy | Targeted Drug Monitoring | Ai Analysis | Malignant Tumors | Translational Research |
